{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:10:16Z","timestamp":1760191816946,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.reprotox.2018.06.007","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T08:43:51Z","timestamp":1529397831000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Farletuzumab, a monoclonal antibody directed against folate receptor alpha, shows no evidence of teratogenicity in cynomolgus monkeys"],"prefix":"10.1016","volume":"79","author":[{"given":"Tomoyuki","family":"Moriyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Hutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1768-9548","authenticated-orcid":false,"given":"Danielle","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2018.06.007_bib0005","doi-asserted-by":"crossref","first-page":"598S","DOI":"10.1093\/ajcn\/85.2.598S","article-title":"In utero physiology: role of folic acid in nutrient delivery and fetal development","volume":"85","author":"Antony","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/tera.1420150110","article-title":"Embryotoxicity of the folate antagonist methotrexate in rats and rabbits","volume":"15","author":"Jordan","year":"1977","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcn\/82.1.188","article-title":"Maternal methylentetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice","volume":"82","author":"Li","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0020","article-title":"Effects and safety of periconceptional oral folate supplementation for preventing birth defects","volume":"12","author":"De-Regil","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/humupd\/dmp052","article-title":"Teratogenic mechanisms of medical drugs","volume":"16","author":"van Gelder","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/OGX.0000000000000405","article-title":"Risk factors for birth defects","volume":"72","author":"Harris","year":"2017","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/13861","article-title":"Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development","volume":"23","author":"Piedrahita","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0040","series-title":"Proceedings of the 12th International Symposium on Pteridines and Folates","first-page":"637","article-title":"Folate transport abnormalities and congenital defects, chemistry and biology of pteridines and folates","author":"Finnell","year":"2018"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/bdra.10088","article-title":"Antibodies to folate receptors impair embryogenesis and fetal development in the rat","volume":"67","author":"da Costa","year":"2003","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"issue":"3","key":"10.1016\/j.reprotox.2018.06.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152249","article-title":"Exposure to folate receptor alpha antibodies during gestation and weaning leads to severe behavioral deficits in rats: a pilot study","volume":"11","author":"Sequeira","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa031145","article-title":"Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect","volume":"350","author":"Rothenberg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jri.2008.08.002","article-title":"Autoantibodies to folate receptor during pregnancy and neural tube defect risk","volume":"79","author":"Cabrera","year":"2008","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0065","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/humrep\/der144","article-title":"Association between inhibited binding of folic acid to folate receptor \u03b1 in maternal serum and folate-related birth defects in Norway","volume":"26","author":"Boyles","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0070","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/bdra.23436","article-title":"Folate receptor autoantibodies in pregnancy related complications","volume":"103","author":"Shapira","year":"2015","journal-title":"Birth Defects Res. (Part A)"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bdra.23517","article-title":"Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population","volume":"106","author":"Yang","year":"2016","journal-title":"Birth Defects Res. (Part A)"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2017.04.006","article-title":"Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer","author":"O\u2019Shannessy","year":"2017","journal-title":"Genomics"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2013.03.002","article-title":"Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer","volume":"129","author":"Armstrong","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0090","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1200\/JCO.2015.63.2596","article-title":"A randomized, double-blind, placebo-controlled, phase III study to assess efficacy and safety of weekly farletuzumab in combination with carboplatin and taxane in patients with ovarian cancer in first platinum-sensitive relapse","volume":"34","author":"Vergote","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00280-012-1890-2","article-title":"Farletuzumab, an anti-folate receptor \u03b1 antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro","volume":"70","author":"Kamen","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.18632\/oncotarget.412","article-title":"Characterization of the human folate receptor alpha via novel antibody-based probes","volume":"2","author":"O\u2019Shannessy","year":"2011","journal-title":"Oncotarget"},{"unstructured":"ICH [International Conference on Harmonisation]. S9, Nonclinical evaluation for anticancer pharmaceuticals. October 2009. (Accessed at https:\/\/www.ich.org).","key":"10.1016\/j.reprotox.2018.06.007_bib0105"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ajp.1350150405","article-title":"Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta): a comparison by ultrasonography","volume":"15","author":"Tarantal","year":"1988","journal-title":"Am. J. Primatol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0115","series-title":"Blaustein\u2019s Pathology of the Female Genital Tract","first-page":"1103","article-title":"Diseases of the placenta","author":"Gershell","year":"2002"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0120","series-title":"Histology for Pathologists","first-page":"961","article-title":"Placenta","author":"Lewis","year":"1997"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0125","first-page":"221","article-title":"The pathology of the rhesus monkey placenta","volume":"166","author":"Myers","year":"1972","journal-title":"Acta Endocrinol. Sppl."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0684.1997.tb00222.x","article-title":"Frequency of spontaneous congenital defects in rhesus and cynomolgus macaques","volume":"26","author":"Peterson","year":"1997","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1469-0705.2002.00632.x","article-title":"First-trimester diagnosis of fetal hepatic cyst","volume":"19","author":"Berg","year":"2002","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2214\/ajr.147.3.537","article-title":"Nonparasitic splenic cysts: a report of 52 cases with radiologic-pathologic correlation","volume":"147","author":"Dachman","year":"1986","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ciresp.2011.05.002","article-title":"Benign non-parasitic hepatic cystic tumours","volume":"89","author":"Ramia","year":"2011","journal-title":"Cir. Esp."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0150","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00000658-197406000-00018","article-title":"Cystic disease of the liver","volume":"179","author":"Sanfelippo","year":"1974","journal-title":"Ann. Surg."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1590\/S0100-69912010000600011","article-title":"Non-parasitic splenic cysts","volume":"37","author":"Schlittler","year":"2010","journal-title":"Rev. Col. Bras. Cir."},{"key":"10.1016\/j.reprotox.2018.06.007_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1148\/radiographics.16.1.107","article-title":"Cystic masses of the spleen: radiologic-pathologic correlation","volume":"16","author":"Urrutia","year":"1996","journal-title":"Radiographics"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/bdrb.21089","article-title":"Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis","volume":"98","author":"Bowman","year":"2013","journal-title":"Birth Defects Res. (Part B)"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0170","first-page":"52045","article-title":"Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc receptor engagement","volume":"8","author":"Kline","year":"2017","journal-title":"Onco Target"},{"key":"10.1016\/j.reprotox.2018.06.007_bib0175","series-title":"Proceedings of the 8th Annual World ADC","article-title":"MORAb-202, a novel antibody-drug conjugates (ADC) comprised of farletuzumab conjugated with eribulin, exhibits long-lasting targeted antitumor activity and payload-mediated bystander effects on the tumor microenvironment, poster #29","author":"Furuuchi","year":"2017"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623817307505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623817307505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:47:45Z","timestamp":1760190465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623817307505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"alternative-id":["S0890623817307505"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2018.06.007","relation":{},"ISSN":["0890-6238"],"issn-type":[{"type":"print","value":"0890-6238"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farletuzumab, a monoclonal antibody directed against folate receptor alpha, shows no evidence of teratogenicity in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2018.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}